Latest Insights on SMED
Tesla Tears & Nio’s Next, Sonos Breaks The Silence, China’s Tech Terror
August 16, 2021 Great StuffGo Home, Tesla … You’re Drunk? Oh oh, here they come. Watch out, Tesla (Nasdaq: ), they’ll chew you up. Oh oh, here they come… The National Highway Traffic Safety Administration (NHTSA) is far from a maneater … sorry, Hall & Oates … but it is about to make Tesla’s life much more complicated. This […]
Pfizer’s Pforce Awakens, Apple Strikes Back & CVS’s New Hope
May 4, 2021 Great StuffMay The Pfourth Be With You Great Ones, I don’t know if we officially have a winner in the COVID-19 vaccine race, but we certainly have a new front-runner: Pfizer (NYSE: ). I know. I didn’t see it coming either. Apparently, Pfizer makes more than just Viagra. Who knew? OK, I knew. But I didn’t […]
The Pandemic Shift to Telemedicine: 2 ETFs to Buy for Profits(5-minute read) The technology isn’t new … but it’s finally going mainstream. Virtual doctor’s visits, telehealth, remote medicine … it all means the same thing. It’s finally time to have house calls on our smartphones. Here are two ETFs that will benefit.
Trashing the Economy; Croc’s Idea of Beauty
July 30, 2020 Great Stuff“It’s the Economy, Stupid.” Welcome to Reader Feedback day here at Great Stuff! We’ll get to your emails in a moment — You, you you … always about you isn’t it? — but first, let’s address that big-lettered quote up there, shall we? As some of you may remember, that quote comes from former U.S. […]
TransMedics’ $105 Million IPO Spotlights Organ Transplant OpportunityThe global organ-transplantation market is projected to hit $51 billion in just six years. Here’s how to double your money and cash in with an ETF, and double your money in a year.